Shopping Cart 0
Cart Subtotal

MediPoint: Pancreatic and Biliary Stents-Europe Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


MediPoint: Pancreatic and Biliary Stents-Europe Analysis and Market Forecasts


The pancreatic and biliary stents market is driven by two procedures: endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. There are four primary pancreatic and biliary stents; the covered metal stents, the partially covered metal stents, the non-covered metal stents, and plastic stents. The market will continue to grow as cancer prevalence increases and patients become more familiar with stenting as a treatment option. This report examines the pancreatic and biliary stents market in 21 major European markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and the UK.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the European market.

Key Questions Answered

What is the current and future pancreatic and biliary stents market outlook in Europe? What trends are affecting the European market?

What is the competitive landscape and market share of major players in the pancreatic and biliary stents space in Europe?

What are the key, high growth markets that pancreatic and biliary stents manufacturers should expand into? Which market segments are growing the fastest?

What is physician perception and market outlook of pancreatic and biliary stents?


Data tables covering sales volume, average selling price, market values, and company share analysis

Competitive Assessment of major players in the market and currently marketed pancreatic and biliary stents

In-depth Analysis of the pancreatic and biliary stents market revenue by segment and market outlooks by region and country from 2014 to 2023.

Other key topics covered include market characterization, market dynamics, and market trends

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving pancreatic and biliary stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the pancreatic and biliary stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific pancreatic and biliary stents market from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.


Table Of Content


Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 8

3.3 Key Players 8

3.4 Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

5 Market Outlook 10

5.1 Procedure Trends 10

5.2 Pricing Trends 14

5.3 Revenue Trends 18

5.4 Company Share Analysis 22

6 Market Insights 23

6.1 Europe 23

6.1.1 Denmark, Finland, Norway, and Sweden 23

6.1.2 Belgium, France, and Netherlands 23

6.1.3 Austria, Germany, and Switzerland 24

6.1.4 UK and Ireland 24

6.1.5 Italy, Portugal, and Spain 24

6.1.6 Czechia, Hungary, and Poland 25

6.1.7 Russia, Turkey, and Greece 25

7 Competitive Assessment 26

7.1 Boston Scientific 26

7.1.1 Overview 26

7.1.2 Portfolio Assessment 26

7.1.3 Competitive Positioning 26

7.2 Cook Medical 26

7.2.1 Overview 26

7.2.2 Portfolio Assessment 27

7.2.3 Competitive Positioning 27

7.3 ELLA-CS 27

7.3.1 Overview 27

7.3.2 Portfolio Assessment 28

7.3.3 Competitive Positioning 28

7.4 Taewoong Medical 28

7.4.1 Overview 28

7.4.2 Portfolio Assessment 28

7.5 Others 29

8 Appendix 30

8.1 Bibliography 30

8.2 Abbreviations 31

8.3 Methodology 32

8.3.1 Overview 32

8.3.2 Coverage 32

8.3.3 Secondary Research 32

8.3.4 Forecasting Methodology 33

8.3.5 Primary Research Summary 34

8.4 About MediPoint 35

8.5 About GlobalData 35

8.6 Contact Us 35

8.7 Disclaimer 36

List Of Figure

List of Figures

Figure 1: Pancreatic and Biliary Stents Sales for Europe by Country, 2016 and 2023 7

List Of Table

List of Tables

Table 1: Key Metrics in the Europe Pancreatic and Biliary Stents Market 6

Table 2: Europe Pancreatic and Biliary Stenting Procedure Volume Forecast, 2014-2023 10

Table 3: Europe Pancreatic and Biliary Stents Average Selling Price Forecast, 2014-2023 14

Table 4: Europe Pancreatic and Biliary Stents Sales Forecast ($M), 2014-2023 18

Table 5: Europe Company Share Analysis, 2016 22

Table 6: Product Portfolio-Boston Scientific 26

Table 7: Product Portfolio-Cook Medical 27

Table 8: Product Portfolio-ELLA-CS 28

Table 9: Product Portfolio-Taewoong Medical 28

Table 10 Other Players Assessment 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Boston Scientific, Cook Medical, ELLA-CS, Taewoong Medical